In bladder cancer, the PI3K-AKT-mTOR pathway was associated with sialyl-Tn antigen, whereby inhibition of mTOR led to reduced expression of this sialyl-Tn antigen (48). The gene discussed is AKT1; the disease is urinary bladder cancer.